B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Furie RA, et al. Ann Rheum Dis. 2022 Jan;81(1):100-107. https://pubmed.ncbi.nlm.nih.gov/34615636/ …